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1,2 Improved risk stratification is crucial to optimize patient care and requires development of more sensitive tools to identify high-risk patients. Because blood pressure (BP) in the brachial artery differs from the BP in the aorta, to which the heart and brain are exposed, cardiovascular risk assessment based on aortic BP could potentially be superior to assessment based on office BP measured at the level of the brachial artery. 3 However, the prognostic value of aortic BP remains unresolved, as aortic BP estimated noninvasively has been found to predict cardiovascular events in some, [4] [5] [6] [7] but not all, 8, 9 studies. The gold-standard method for assessing aortic BP is by invasive measurements. Only 2 studies of limited size and duration have assessed the association between invasively measured aortic BP and cardiovascular risk yielding conflicting results.
focused on this group. The aim of the present cohort study was to examine whether invasively measured aortic systolic BP improves prediction of stroke, MI, and all-cause mortality beyond risk prediction by office systolic BP in patients with and without diabetes mellitus who underwent elective coronary angiography (CAG) because of stable angina pectoris.
Methods
This study was conducted using medical databases in Denmark. Denmark has free, universal tax-supported health care with unrestrained access to general practitioners and hospitals. Accurate linkage of all medical registries is possible through the unique central personal registry number. 13 In this study, patient data in The Western Denmark Heart Registry covering 3 million inhabitants 14 was linked to outcome data in The Danish National Registry of Patients 15 and The Danish Civil Registration System. 13 The Western Denmark Heart Registry collects patient and procedure data from all cardiac intervention centers in Western Denmark. 14 The registry was used to identify all elective CAG procedures performed between January 1, 2001 , and December 31, 2012. For the present analysis, we considered patients without previous MI, stroke, heart failure, or valvular disease referred for CAG with suspicion of stable angina pectoris. The first CAG during the inclusion period was defined as the index CAG.
Office BP and invasively measured aortic BP data from the The Western Denmark Heart Registry were used in the analysis. As systolic BP increases when the pulse wave progresses from the aorta toward the peripheral arteries due to pulse wave amplification, while diastolic BP remains constant within a few mm Hg, 3 we focused analyses on systolic BP. The office BP registered in the The Western Denmark Heart Registry was measured by the referring general practitioner or during the CAG admission. Information regarding measurement method (ausculatory/ oscillometric) or number of BP measurements was not available. The BP in the ascending aorta was measured during the CAG procedure using a fluid-filled catheter. The catheters were routinely calibrated before the CAG according to local standard-operating procedures.
Using central personal registry numbers, we linked the cohort patients to the The Danish National Registry of Patients and The Danish Civil Registration System. 13 The Danish National Registry of Patients was used to identify admissions for MI and stroke. Analyses were made separately for the first stroke and the first MI event occurring after the index CAG date.
Data regarding all-cause mortality were retrieved from the The Danish Civil Registration System. 13 This system records vital statistics including date of birth, change of address, date of emigration, and exact date of death for the Danish population. The study was approved by the Danish Data Protection Agency. In accordance with Danish law, approval from an ethics committee and informed consent from the patients were not required for this registry study.
Statistical Analysis
The study population consisted of 21 908 patients (18 824 without diabetes mellitus and 3084 with diabetes mellitus) with complete data on the following baseline variables: age, sex, diabetes mellitus (yes/ no), smoking (never/previous versus current), body mass index, previous MI, previous stroke, other comorbidity (modified Charlson index excluding previous stroke and MI [0/1/≥2]), antihypertensive treatment (yes/no), lipid-lowering treatment (yes/no), atrial fibrillation, and extent of vessel disease based on the CAG (none/diffuse atherosclerosis without significant (>50%) stenosis/1, 2, or 3 vessel disease). These variables were assessed for inclusion in multivariate Cox models with and without stratification for diabetes mellitus as described in the online only Data Supplement. To avoid bias from severe disease at baseline and procedure-related events, a 180-day quarantine from the date of the CAG was implemented when defining the index date.
We examined whether office systolic BP and invasively measured aortic systolic BP were associated with the end points stroke, MI, and all-cause mortality. Stroke and MI were classified as fatal if the patients died within 30 days after the event. The final model for stroke included age, sex, smoking, and comorbidity. The final model for MI and all-cause mortality additionally included the number of diseased vessels. The unstratified models were additionally adjusted for diabetes mellitus (yes/no). We tested for interaction between the effects of diabetes mellitus and the BP variables on outcomes. Significant interaction terms were observed in the stroke model. Second-order polynomials of the BP variables were tested for inclusion in all models and were significant in the all-cause mortality model. To facilitate interpretation, aortic and office systolic BP were included categorized (≤110, 111-130, 131-140 [reference category], 141-160, 161-180, or >180 mm Hg). Serum creatinine data and ejection fraction data were available for 19 924 and 13 051 patients, respectively. Subgroup analyses with these parameters are reported in the Results section of the online-only Data Supplement.
The added prediction, discrimination, and reclassification by aortic BP beyond office BP were assessed using complementary strategies: (1) aortic and office systolic BP were included in the same Cox models. (2) Discrimination was assessed with Harrell's C, 16 and (3) Reclassification was assessed by the continuous Net Reclassification Index 17 (online-only Data Supplement). A 2-tailed P value <0.05 was considered to indicate statistical significance. All data were analyzed using Stata version 14.0 (Stata Corp LP, College Station, TX).
Results
During a median follow-up of 3.7 years (range: 0. Baseline characteristics for the total cohort and stratified by diabetes mellitus status are shown in Table 1 . Patients with diabetes mellitus were slightly older, a higher proportion were men, and fewer were current smokers. More patients with diabetes mellitus received antihypertensive and lipid-lowering treatment; they had more comorbidity and more extensive coronary vessel atherosclerosis. Moreover, office and aortic systolic and diastolic BP were marginally higher among patients with diabetes mellitus.
Associations Between Office and Aortic Systolic BP and Stroke
We observed that diabetes mellitus significantly modified the association with stroke for both office and aortic systolic BP (online-only Data Supplement). Accordingly, results are reported stratified by diabetes mellitus status ( Table 2) .
Aortic and office systolic BP were associated with stroke risk in both patients with and without diabetes mellitus in crude analyses ( Table 2 ). The association remained statistically significant in the adjusted model only in patients with diabetes mellitus.
Associations Between Office and Aortic Systolic BP and MI
In the total study population, office BP was associated with MI in crude and adjusted analyses, whereas aortic BP was associated with MI only in the crude analysis (Table 2) . When patients were evaluated according to diabetes mellitus status, both aortic and office systolic BP were associated with MI risk in patients without diabetes mellitus, whereas no association was observed in patients with diabetes mellitus.
When all patients were analyzed, office systolic BP <110 mm Hg was significantly associated with increased mortality in the adjusted model (Table 2) . When stratified by diabetes mellitus status, office systolic BP <110 mm Hg was associated with allcause mortality in patients with diabetes mellitus in the adjusted model. No statistically significant association between invasively measured aortic systolic BP and all-cause mortality was observed.
Relative Prognostic Contribution of Office Versus Aortic Systolic BP
The relative prognostic contribution of office versus aortic systolic BP was assessed for the associations where both BP indices were statistically significantly associated with the outcome (ie, stroke in patient with diabetes mellitus and MI in patients without diabetes mellitus). When simultaneously including both aortic and office BP in crude Cox models, office BP remained a significant predictor for MI in patients without diabetes mellitus and for stroke in the patients with diabetes mellitus (Table 3) . In adjusted models, office systolic BP remained significantly associated with stroke. The Pearson correlation between office and aortic systolic BP was 0.53 (P<0.001).
We found no significant differences between aortic and office systolic BP in discriminative power as assessed by Harrell's C in crude and adjusted models (Table 3) .
Reclassification analyses did not show improved reclassification by introducing aortic systolic BP to models with office systolic BP ( Table 3) .
Discussion
We conducted the largest study to date comparing the prognostic potential of invasively measured aortic systolic BP and office BP for the risk of stroke, MI, and all-cause mortality. We found strong evidence that the predictive ability of aortic systolic BP does not exceed that of office systolic BP. Our study is also the first to specifically evaluate aortic BP in patients with diabetes mellitus, and we found no evidence of added prognostic ability of aortic systolic BP beyond office systolic BP even in this high-risk group. The study is also the first to evaluate whether aortic systolic BP improves discrimination and reclassification beyond office systolic BP, and we found no evidence for this in neither patients with or without diabetes mellitus.
For several years, cardiovascular risk assessment based on aortic BP has been proposed as a potentially more sensitive source of prognostic information compared with risk assessment based on office BP. 4, 6, [18] [19] [20] The rationale behind this idea stems mostly from physiology. Systolic BP is amplified as the pulse wave generated by the cardiac systole progresses from the aorta to the peripheral arteries. The amplification varies between individuals, and the systolic BP in the brachial artery may differ significantly from the aortic BP, to which the heart and brain are exposed. 3 Despite this plausible mechanism, the added prognostic value of aortic BP remains debated. 20, 21 Our data extend previous research in several ways. Several studies have assessed the prognostic information of noninvasive estimates of aortic BP for cardiovascular events and mortality. Nominally stronger associations were reported for aortic BP than for office BP in a Taiwanese population 7, 22 and in selected patient groups such as Native Americans, 6 patients with end-stage renal disease, 4 and community dwelling geriatric individuals. 5 On the contrary, office systolic BP had Results are presented for all participants and stratified by diabetes status. Results for stroke and acute myocardial infarction are presented per 10 mm Hg difference. Results for all-cause mortality are presented per blood pressure category in comparison to the reference category (131-140 mm Hg). The adjusted model for stroke includes age, sex, smoking (never/previous vs current), and modified Charlson comorbidity index (0/1/≥2). The adjusted model MI and all-cause mortality includes age, sex, smoking (never/ previous vs current), modified Charlson comorbidity index (0/1/≥2), and number of diseased vessels (none/diffuse atherosclerosis without significant [>50%] stenosis/1, 2, or 3 vessel disease). The unstratified models are additionally adjusted for diabetes mellitus (yes/no). BP indicates blood pressure; CI, confidence interval; and HR, hazard ratio. *The interaction term diabetes mellitus×office systolic BP was significant both in the crude model and adjusted model (P=0.02 and P=0.01, respectively), and diabetes mellitus×aortic systolic BP was significant in the adjusted model (P=0.04). Accordingly, only the results from the stratified analyses in the patients with and without diabetes mellitus are reported.
†P<0.05. ‡P<0.001. §P<0.01. ‖P value for comparison with reference group (systolic BP 131-140 mm Hg).
by guest on November 12, 2017 http://hyper.ahajournals.org/ Downloaded from a stronger predictive ability than aortic BP in elderly female hypertensive patients 8 ; and in the Framingham study, aortic BP was not associated with major cardiovascular events. 9 The prognostic impact of invasively measured aortic BP has been assessed in 2 previous studies. Aortic pulse pressure and pulsatility were associated with a combined cardiovascular outcome in 1109 patients undergoing CAG, but the prognostic information was not reported for office BP parameters. 11 In 324 patients undergoing CAG aortic diastolic BP, but neither aortic nor office systolic BP predicted, a combined end point of major adverse cardiovascular events and aortic diastolic BP and pulse pressure were associated with all-cause mortality in a multivariate analysis. 10 Previous studies focused on the strength of association of aortic BP and office BP with major adverse cardiovascular events The prognostic contribution of aortic and office systolic BP was assessed using complementary statistical strategies: (1) By simultaneously including both BP indices in the same Cox models (crude and adjusted), (2) discrimination was assessed based on Harrell's C calculated for Cox models (crude and adjusted) fitted with either aortic systolic BP or office systolic BP. (3) Improvement in reclassification by adding aortic systolic BP to models with office systolic BP (crude and adjusted) was assessed by the continuous net reclassification index. Adjusted models for stroke includes age, sex, smoking (never/previous vs current) and modified Charlson comorbidity index (0/1/≥2). Adjusted model myocardial infarction includes age, sex, smoking (never/previous vs current), modified Charlson comorbidity index (0/1/≥2), and number of diseased vessels (none/diffuse atherosclerosis without significant (>50%) stenosis/1, 2, or 3 vessel disease). BP indicates blood pressure; CI, confidence interval; and HR, hazard ratio. and all-cause mortality. However, a new risk marker should demonstrate added predictive value beyond current best practice by improvement of discrimination and risk classification 23 ; that is, aortic systolic BP would need to demonstrate added predictive value to a risk prediction model including office systolic BP. We used several complementary strategies to compare the 2 BP indices. We found no indication of superiority of invasively measured systolic BP as compared with office systolic BP in Cox models. When office and aortic BP were tested in the same models, aortic systolic BP lost statistical significance. When we evaluated discrimination and reclassification, the data did not show improvement in discrimination and reclassification in models with aortic BP as compared with office BP.
Office and aortic systolic BP predicted stroke in patients with diabetes mellitus. The direction of the association was the same in the patients without diabetes mellitus, but the significant interaction terms in the unstratified model indicated that the association is of different magnitude according to diabetes mellitus status. If different referral patterns for CAG were practiced in patients with versus without diabetes mellitus, this could induce a degree of selection bias. Although we adjusted for confounders, the different results in the 2 patient groups may to some extent reflect residual confounding. Information bias seems unlikely to have influenced the results given the standardized recording of outcomes in the Danish registers. From a physiological point of view, increased aortic stiffness in patients with diabetes mellitus may lead to increased transmission of pulsatile pressure to the cerebral circulation 24 and could contribute to the different results according to diabetes mellitus status.
Office and aortic systolic BP did not predict MI in the diabetes mellitus subgroup at a statistically significant level. However, given the smaller diabetic subpopulation, the fact that the direction of the association was the same in both subgroups and that the diabetes×BP interaction terms were nonsignificant, it seems unlikely that the association between either BP measure and MI differs by diabetes mellitus status.
Office systolic BP <110 mm Hg was associated with increased all-cause mortality in the model with all patients and in patients with diabetes mellitus. The increased risk at the lower end of the continuous distribution may be the result of reverse causation, that is, a residual impact of pre-existing nonischemic comorbidity is likely to drive the elevated all-cause mortality we observed in the lowest BP category. 25 Data from intervention studies are needed to explore the causality of the observed association in further detail. High systolic BP was associated with stroke and MI. The majority of the cardiovascular events were nonfatal and may explain the absence of association between the high BP categories and all-cause mortality.
Aortic systolic BP and office systolic BP were of similar magnitude in this study. This observation may seem to conflict with the phenomenon of aortic-brachial pulse pressure amplification found in studies that assessed intra-arterial BP using invasive catheterization. 26, 27 Yet, the apparent discrepancy may be explained by the tendency of cuff-based measurements to underestimate intra-arterial brachial systolic BP. 28 This measurement bias in the opposite direction of the intra-arterial pressure amplification will reduce the difference between the true aortic pressure and the systolic BP measured by cuff at the level of the brachial artery. 29 Office systolic BP measured in everyday practice may thus on average be an adequate estimate of the aortic systolic BP, and this may explain the welldocumented prognostic value of office systolic BP.
Strengths and Limitations
This study is the largest to date based on data from invasive aortic BP measurements and is based on more events and patients than all previous noninvasive studies combined. The study was conducted in a country with universal health care, reducing selection bias because of selective inclusion of specific hospitals, health insurance systems, or age groups. Follow-up and outcome ascertainment were standardized through registers, and patients were followed up until death, emigration, or end of follow-up. Information bias or differential outcome misclassification is therefore unlikely to have affected our results. Office BP was measured by the referring physician or during the admission for the CAG and thus not under the same standardized conditions as invasively measured aortic BP. Yet, this source of additional random error in office BP measures would a priori confer a prognostic advantage for the invasive BP. Pulse wave data were not available for analysis. The study population consisted of patients referred for elective CAG on suspicion of angina pectoris. Thus, our results may not be directly applicable to patients with hypertension or diabetes mellitus in the general population. As in all observational studies, residual confounding may still affect the association between BP and outcomes but is unlikely to substantially affect the comparisons of office versus aortic systolic BP.
In conclusion, invasively measured aortic systolic BP and cuff-based office systolic BP both predicted MI in patients without diabetes mellitus and stroke in patients with diabetes mellitus. Aortic systolic BP did not add prognostic information about cardiovascular outcomes and mortality beyond office systolic BP in patients undergoing elective CAG.
Perspectives
During the past decade, cardiovascular risk assessment based on aortic BP has been suggested as potentially superior to office BP. However, no previous studies have assessed whether aortic BP confers added discrimination or reclassification beyond office BP. In the largest study to date, we found strong evidence that the predictive ability of invasively measured aortic systolic BP, the gold-standard method, does not exceed office systolic BP and that invasively measured aortic systolic BP does not improve discrimination or reclassification beyond office BP. Consequently, our data do not support the introduction of noninvasive estimates of aortic systolic BP by currently available commercially devices as a novel risk marker in cardiovascular risk stratification. However, analysis of other pulse wave characteristics may provide added information beyond office BP and could potentially improve discrimination and reclassification in cardiovascular risk stratification.
What Is New?
• The largest study to date covering the prognostic potential of invasively measured aortic systolic blood pressure (BP) as compared with office systolic BP for stroke, myocardial infarction, and all-cause mortality. Multivariate Cox models were used to assess the association with outcomes. Whether aortic BP conferred added discrimination and reclassification beyond office BP was assessed using Harrell's C and the Continuous Net Reclassification Index.
What Is Relevant?
• Both office and aortic systolic BP were associated with stroke in patients with diabetes mellitus and with myocardial infarction in patients without diabetes mellitus. However, in models including both BP measurements, aortic BP lost statistical significance and aortic BP did not confer improvement in either C-statistics or net reclassification analysis. 
Supplemental methods

Supplemental information for statistical analyses
The study population for this study included 31,123 patients (26,793 without diabetes and 4,330 with diabetes). To avoid bias from severe disease at baseline and procedure-related events, a 180 day quarantine from the date of the CAG was implemented when defining the index date. Patients with events during the quarantine period and patients without events who were censored during the quarantine (i.e. had <180 days follow-up) were excluded from the analysis. 180 days were subtracted from follow-up time for the remaining patients. After this exclusion, the study population consisted of 29,460 patients. Data on BP or other risk factors was not available for 8, 192 participants. The final cohort consisted of 21,908 patients (18,824 without diabetes and 3,084 with diabetes). We examined whether office systolic BP and invasively measured aortic systolic BP were associated with the end-points stroke, MI and all-cause mortality. The endpoints stroke and myocardial infarction were retrieved from the Danish National Registry of Patients and death from The Danish Civil Registration System. The sensitivity and positive predictive value of diagnoses in the Danish National Registry of Patients have been shown to be 93% and 80%, respectively, for MI 1 and 79% and 79%, respectively, for stroke 2 . Stroke and MI were classified as fatal if the patients died within 30 days after the event. The predictive power of the BP indices was assessed by Cox-proportional hazards regression models. The proportional hazards assumption was tested by visual assessment of Schoenfeld residuals and log(-log) plots. Second order polynomials were used to assess non-linearity of the association between the BP parameters and the outcomes. Complete baseline data was available for the following variables: age, sex, BMI, smoking, lipid-lowering treatment, antihypertensive treatment, atrial fibrillation, Charlson's comorbidity index and number of diseased vessels. These variables were assessed for inclusion in the adjusted models with and without stratification for diabetes. The final model for stroke included age, sex, smoking and comorbidity. Model fit was assessed by the likelihood ratio test for nested models and by Akaike´s information criterion and the Bayesian information criterion for non-nested models. The final model for MI and all-cause mortality additionally included the number of diseased vessels. The unstratified models were additionally adjusted for diabetes status. Interaction between diabetes-status and the BP variables was assessed for all models. Significant interaction terms were observed in the model for stroke. Second order polynomials of the BP variables were tested for inclusion in all models, but were only significant in the models for all-cause mortality. Serum creatinine data and EF data were available for 19,924 and 13,051 patients, respectively. Subgroup analyses with these parameters are reported in the supplementary data. To assess whether invasively measured aortic systolic BP improved prediction of stroke, MI and all-cause mortality beyond risk prediction by office systolic BP complementary strategies was applied: i) Both aortic and office systolic BP were included in the same Cox model models. ii) Discrimination was assessed based on Harrell´s C. The c-statistic may be considered the equivalent of area-under-the curve for censored data. and ranges from 0 to 1 3 . Harrell´s C was calculated for non-nested models fitted with aortic BP and office BP, respectively, and the difference between Harrell´s C was tested by bootstrapping with 200 repetitions. iii) Reclassification was assessed by the continuous Net Reclassification Index (NRI) 4 . A two-tailed p-value less than 0.05 was considered to indicate statistical significance. All data was analyzed using the statistical software Stata version 14.0 (StataCorp LP, TX, USA).
Supplemental information for Results
Stroke:
We observed significant interaction between the effects of both diabetes and office systolic BP and between diabetes and aortic systolic BP for the association with stroke. In the total study population (including patients with and without diabetes), the interaction term diabetes x office systolic BP was significant both in the crude model and adjusted model (p=0.02 and p=0.01 respectively), and diabetes x aortic systolic BP was significant in the adjusted model (p=0.04). Accordingly, only the results from the stratified analyses in the patients with and without diabetes are reported ( Table 2) .
Subgroup analyses
Serum creatinine data and EF data were available for 19,924 and 13,051 patients, respectively. Subgroup analyses with these parameters are reported in the supplementary data table S1 and S2.
Inclusion of creatinine in the models did not affect the association between BP, stroke and MI. Office systolic BP remained associated with risk of MI in the patients without diabetes after adjustment for EF, whereas aortic systolic BP did not. The direction of the association between aortic and office systolic BP and stroke remained the same, yet was attenuated in the subgroup with EF data. A significant interaction term between diabetes x office systolic BP was found (p=0.03) for the association with MI in the subgroup with ejection fraction data and accordingly results from a joint model are not reported (Table S2) .
Adjustment for creatinine did not alter the associations between office systolic BP <110 mmHg and mortality (Table S1 ). The direction of the association with all-cause mortality remained the same in the <110 mmHg group with adjustment for ejection fraction, yet was attenuated (Table S2) 
